Cargando…
Case Report: ASXL1, RUNX1, and IDH1 mutation in tyrosine kinase-independent resistant chronic myeloid leukemia progressing to chronic myelomonocytic leukemia-like accelerated phase
Although the majority of patients with chronic myeloid leukemia (CML) enjoy an excellent prognosis tyrosine kinase inhibitor (TKI) therapy, resistance remains a significant clinical problem. Resistance can arise from mutations in the kinase domain of ABL preventing drug binding, or due to ill-define...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513384/ https://www.ncbi.nlm.nih.gov/pubmed/37746298 http://dx.doi.org/10.3389/fonc.2023.1217153 |
_version_ | 1785108557653344256 |
---|---|
author | Oyogoa, Emmanuella Streich, Lukas Raess, Philipp W. Braun, Theodore |
author_facet | Oyogoa, Emmanuella Streich, Lukas Raess, Philipp W. Braun, Theodore |
author_sort | Oyogoa, Emmanuella |
collection | PubMed |
description | Although the majority of patients with chronic myeloid leukemia (CML) enjoy an excellent prognosis tyrosine kinase inhibitor (TKI) therapy, resistance remains a significant clinical problem. Resistance can arise from mutations in the kinase domain of ABL preventing drug binding, or due to ill-defined kinase-independent mechanisms. In this case report, we describe the case of a 27-year-old woman with a long-standing history of chronic phase (CP) CML who developed kinase-independent resistance with mutations in ASXL1 and RUNX1. As a consequence of uncontrolled disease, she progressed to a chronic myelomonocytic leukemia-like (CMML) accelerated phase (AP) disease with the acquisition of a mutation in IDH1. This disease progression was associated with the development of an inflammatory serositis, a phenomenon that has been described in CMML but not in AP-CML. This case presents key features of kinase-independent resistance with insight into potential mechanisms, highlights management challenges, and describes a novel systemic inflammatory response that occurred in this patient upon disease progression. |
format | Online Article Text |
id | pubmed-10513384 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105133842023-09-22 Case Report: ASXL1, RUNX1, and IDH1 mutation in tyrosine kinase-independent resistant chronic myeloid leukemia progressing to chronic myelomonocytic leukemia-like accelerated phase Oyogoa, Emmanuella Streich, Lukas Raess, Philipp W. Braun, Theodore Front Oncol Oncology Although the majority of patients with chronic myeloid leukemia (CML) enjoy an excellent prognosis tyrosine kinase inhibitor (TKI) therapy, resistance remains a significant clinical problem. Resistance can arise from mutations in the kinase domain of ABL preventing drug binding, or due to ill-defined kinase-independent mechanisms. In this case report, we describe the case of a 27-year-old woman with a long-standing history of chronic phase (CP) CML who developed kinase-independent resistance with mutations in ASXL1 and RUNX1. As a consequence of uncontrolled disease, she progressed to a chronic myelomonocytic leukemia-like (CMML) accelerated phase (AP) disease with the acquisition of a mutation in IDH1. This disease progression was associated with the development of an inflammatory serositis, a phenomenon that has been described in CMML but not in AP-CML. This case presents key features of kinase-independent resistance with insight into potential mechanisms, highlights management challenges, and describes a novel systemic inflammatory response that occurred in this patient upon disease progression. Frontiers Media S.A. 2023-09-07 /pmc/articles/PMC10513384/ /pubmed/37746298 http://dx.doi.org/10.3389/fonc.2023.1217153 Text en Copyright © 2023 Oyogoa, Streich, Raess and Braun https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Oyogoa, Emmanuella Streich, Lukas Raess, Philipp W. Braun, Theodore Case Report: ASXL1, RUNX1, and IDH1 mutation in tyrosine kinase-independent resistant chronic myeloid leukemia progressing to chronic myelomonocytic leukemia-like accelerated phase |
title | Case Report: ASXL1, RUNX1, and IDH1 mutation in tyrosine kinase-independent resistant chronic myeloid leukemia progressing to chronic myelomonocytic leukemia-like accelerated phase |
title_full | Case Report: ASXL1, RUNX1, and IDH1 mutation in tyrosine kinase-independent resistant chronic myeloid leukemia progressing to chronic myelomonocytic leukemia-like accelerated phase |
title_fullStr | Case Report: ASXL1, RUNX1, and IDH1 mutation in tyrosine kinase-independent resistant chronic myeloid leukemia progressing to chronic myelomonocytic leukemia-like accelerated phase |
title_full_unstemmed | Case Report: ASXL1, RUNX1, and IDH1 mutation in tyrosine kinase-independent resistant chronic myeloid leukemia progressing to chronic myelomonocytic leukemia-like accelerated phase |
title_short | Case Report: ASXL1, RUNX1, and IDH1 mutation in tyrosine kinase-independent resistant chronic myeloid leukemia progressing to chronic myelomonocytic leukemia-like accelerated phase |
title_sort | case report: asxl1, runx1, and idh1 mutation in tyrosine kinase-independent resistant chronic myeloid leukemia progressing to chronic myelomonocytic leukemia-like accelerated phase |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513384/ https://www.ncbi.nlm.nih.gov/pubmed/37746298 http://dx.doi.org/10.3389/fonc.2023.1217153 |
work_keys_str_mv | AT oyogoaemmanuella casereportasxl1runx1andidh1mutationintyrosinekinaseindependentresistantchronicmyeloidleukemiaprogressingtochronicmyelomonocyticleukemialikeacceleratedphase AT streichlukas casereportasxl1runx1andidh1mutationintyrosinekinaseindependentresistantchronicmyeloidleukemiaprogressingtochronicmyelomonocyticleukemialikeacceleratedphase AT raessphilippw casereportasxl1runx1andidh1mutationintyrosinekinaseindependentresistantchronicmyeloidleukemiaprogressingtochronicmyelomonocyticleukemialikeacceleratedphase AT brauntheodore casereportasxl1runx1andidh1mutationintyrosinekinaseindependentresistantchronicmyeloidleukemiaprogressingtochronicmyelomonocyticleukemialikeacceleratedphase |